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Summary
 
CD94 is a C-type lectin expressed by natural killer (NK) cells and a subset of T cells. Blocking
studies using anti-CD94 mAbs have suggested that it is a receptor for human leukocyte antigen
class I molecules. CD94 has recently been shown to be a 26-kD protein covalently associated
with an unidentified 43-kD protein(s). This report shows that NKG2A, a 43-kD protein, is co-
valently associated with CD94 on the surface of NK cells. Cell surface expression of NKG2A is
dependent on the association with CD94 as glycosylation patterns characteristic of mature pro-
teins are found only in NKG2A that is associated with CD94. Analysis of NK cell clones
showed that NKG2A was expressed in all NK cell clones whose CD16-dependent killing was
inhibited by cross-linking CD94. The induction of an inhibitory signal is consistent with the
presence of two immunoreceptor tyrosine-based inhibitory motifs (V/LXYXXL) on the cyto-
plasmic domain of NKG2A. Similar motifs are found on Ly49 and killer cell inhibitory recep-
tors, which also transmit negative signals to NK cells.
 
N
 
K cells exhibit cytolytic activity against tumors and
virus-infected cells (1). The expression of MHC class
I molecules on target cells confers resistance to NK-medi-
ated lysis (2–4). A number of NK cell receptors have been
identified that interact with MHC class I molecules and
send inhibitory signals to the NK cell. In mice, these recep-
tors are the Ly49 molecules, type II integral membrane
proteins of the C-type lectin superfamily (5–7). In humans,
the best characterized NK cell receptors for HLA class I
molecules are members of the Ig superfamily and have been
termed killer cell inhibitory receptors (KIR) (8–10). In ad-
dition, CD94, a C-type lectin (11) like Ly49, has also been
suggested as a receptor for HLA class I molecules (12–14).
CD94 was originally described as a 70-kD disulfide
bonded dimeric protein that was expressed primarily on
NK cells and a subset of T cells (15). Cross-linking of
CD94 in in vitro cytotoxicity assays leads to one of three
effects on target cells depending on the NK cell clone (16,
17): increased target cell lysis, decreased target cell lysis or
no substantial change in lysis. These different functional
phenotypes, which divide NK cell clones into three distinct
groups, were shown to correlate with different patterns of
intracellular tyrosine phosphorylation (17). The protein se-
quence of CD94 cannot account for the diverse pheno-
types observed after cross-linking CD94 as it has a cytoplas-
mic tail of only seven amino acids, lacking any well defined
signaling motifs (11). Recently CD94 was shown to be a
25–30-kD protein covalently associated with an as yet uni-
dentified protein(s) of 43 kD (14). An understanding of the
basis for the phenotypic differences observed in NK clones
after CD94 cross-linking probably requires the identifica-
tion of the CD94 associated protein(s) and their signaling
potential.
The NKG2 family of genes, designated NKG2A, C, D
and E, was originally identified by screening a subtractive
library enriched for NK- and T cell–specific transcripts (18).
Chromosomal mapping and analysis of the cDNA sequences
showed that like CD94, the NKG2 genes are located in the
NK complex on chromosome 12 and the proteins encoded
by these genes are members of the C-type lectin family
(19). Moreover, Northern blot analysis showed that the
NKG2 mRNAs have a similar tissue distribution to CD94
(19). These observations, coupled with the fact that NKG2A
is 
 
z
 
43 kD in size and contains two immunoreceptor ty-
rosine based inhibitory motifs (ITIM) in its cytoplasmic do-
main, prompted us to explore the possibility that NKG2A
may be the unidentified, covalently-associated partner of
CD94. In this report we show that NKG2A and CD94
form heterodimers which are expressed on the cell surface
of NK cells. Furthermore, the transmission of an inhibitory
signal after CD94 cross-linking correlates with the expres-
sion of NKG2A by NK cell clones. This suggests that the
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CD94/NKG2A heterodimer can deliver an inhibitory sig-
nal to NK cells, presumably mediated by the cytoplasmic
domain of NKG2A.
 
Materials and Methods
 
Cells.
 
NK-92 cells (20) (a gift from Dr. H Klingemann,
Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada)
were maintained in Myelocult H5100 (Stemcell Technologies,
Vancouver, Canada) supplemented with 20 U/ml of rIL-2 (a gift
from Hoffmann-La Roche, Nutley, NJ). The NK cell line YT (a
gift from Dr. J. Ortaldo, Laboratory of Experimental Immunol-
ogy, NCI-FCRDC, Frederick, MD), the T cell line, Jurkat, and
the murine mastocytoma line P815, were grown in RPMI 1640
(Biofluids, Rockville, MD), supplemented with 10% FCS (Hy-
clone, Logan, UT), 1 mM Hepes (Biofluids).
Polyclonal NK cells were obtained from PBMC from healthy
donors using the MACS NK isolation kit (Miltenyi Biotec, In-
corporated, CA). NK cell populations were always 
 
.
 
92% CD56
positive and 
 
,
 
6% CD3 positive.
NK cell clones were generated by seeding NK cells under lim-
iting dilution into U-bottom 96-well plates in the presence of
2 
 
3 
 
10
 
5
 
 irradiated allogeneic feeder cells. Additional feeder cells
(10
 
5
 
) from the same donor were added after 5 d in culture. NK
clones were identified between days 15 and 21 and then ex-
panded. All clones were CD3
 
2
 
, CD16
 
1
 
, CD56
 
1
 
, and CD94
 
1
 
.
 
Antibodies.
 
The anti-CD94-specific mAb (HP-3B1) was pur-
chased from Immunotech (Westbrook, ME), the anti-Ly49C
(5E6) and anti-CD16 (3G8) mAbs were purchased from Phar-
Mingen (San Diego, CA), and the anti-CD3 (UCH-T1), anti-
CD16 (B-E16) and anti-CD56 (B159) mAbs were purchased
from Serotec (Washington, DC). FITC labeled goat anti–mouse
Ig was purchased from Jackson ImmunoResearch Laboratories
Inc. (Westgrove, PA). The NKG2A-specific mAb 1A12 was a
gift from Dr. J.P. Houchins (University of Minnesota, Minneap-
olis, MN).
NKG2A-peptide-specific rabbit antiserum was obtained by
immunization with a peptide containing the amino-terminal 25
amino acids of NKG2A coupled to KLH. Peptide-specific anti-
bodies were purified from the rabbit antiserum using a recombi-
nant form of the entire cytoplasmic domain of NKG2A made in
 
Escherichia coli.
 
 (a gift from Dr. J.P. Houchins) coupled to Emp-
haze (3M) biosupport medium AB1 (Pierce, Rockford, IL).
 
Immunoprecipitations and Immunoblot Analysis.
 
Cells were har-
vested and washed three times in PBS and surface labeled by
incubation with 0.5 mg/ml NHS-LC biotin (Pierce Chem. Co.,
Rockford, IL) for 30 min at room temperature. Cells were
washed three more times in PBS and lysed in a buffer containing
2% Triton X-100, 50 mM Tris (pH 8.0), 0.15 M NaCl, 20 mM
iodoacetamide, 5 mM EDTA at 2 
 
3 
 
10
 
7
 
cells/ml. After preclear-
ing with Sepharose CL4B (Pharmacia Biotech, Uppsala, Sweden),
lysates were incubated for 2 h at 4
 
8
 
C with mAbs or polyclonal
antisera which had previously been adsorbed to protein G agarose
(GIBCO BRL, Gaithersburg, MD). Bound proteins were washed
five times in a buffer containing 2% Triton X-100, 20 mM Tris,
450 mM NaCl and separated by SDS-PAGE. Proteins were
transferred to Immobilon-P and biotinylated proteins were de-
tected by incubation with streptavidin-peroxidase (Amersham Corp.,
Arlington Heights, IL) followed by ECL (Amersham). Immuno-
blot analysis was performed as previously described (21).
 
Glycosidase Digestions.
 
Whole cell lysates or immunoprecipi-
tated proteins were digested with endoglycosidase H
 
f
 
 (New En-
gland Biolabs, Beverly, MA), or mock digested using conditions
specified by the manufacturer. Digested proteins were separated
by SDS-PAGE and analyzed by Western blot as described above.
 
Cytotoxicity Assays.
 
Standard chromium release assays were
used to measure NK cytotoxicity (12). The anti-CD16 mAb 3G8
and the anti-CD94 mAb HP-3B1 were used at final concentra-
tions of 10 
 
m
 
g/ml each.
 
Results and Discussion
 
CD94 was recently shown to be covalently associated
with an unidentified 43-kD protein(s) (14). We hypothe-
sized that the CD94-associated protein may be a member(s)
of the NKG2 family of proteins as they have molecular
masses consistent with that of the CD94-associated pro-
tein(s) and have a similar tissue distribution and structure to
CD94 (19, 22).
We wanted to determine whether NKG2A was associ-
ated with CD94. Initially, three cell lines NK-92, YT and
Jurkat were assessed for NKG2A expression by Western
blot. Analysis with anti-NKG2A peptide Ab showed that
no NKG2A reactive proteins could be detected in Jurkat
cells (Fig. 1). Under reducing conditions, proteins with mole-
cular masses of 40–45 kD and 
 
z
 
35 kD could be detected
in NK-92 and 
 
z
 
40 kD and 
 
z
 
35 kD in YT. Under non-
reducing conditions, the major species detected in YT cells
had a molecular mass of 
 
z
 
40 kD similar to that observed
under reducing conditions whereas in NK-92 cell lysates the
major species had a molecular mass of 
 
z
 
70 kD. A 35-kD
protein with similar mobility to that observed under re-
duced conditions was again detected in both NK-92 and
YT cell lysates. These data indicate that NKG2A is co-
valently associated with another protein which is present in
NK-92 but absent in YT. Unlike NK-92, YT does not ex-
Figure 1. NKG2A is covalently associated with CD94. Lysates from ei-
ther Jurkat, YT or NK-92 cells, together with anti-CD94 or control (anti-
Ly49) immunoprecipitates (IP) from NK-92 were separated by SDS-PAGE
under reducing or non-reducing conditions and analyzed by Western blot
with anti-NKG2A peptide-specific Ab. 
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press CD94, as assessed by flow cytometry (data not shown),
which suggested that CD94 could be the heterodimer part-
ner of NKG2A.
To test directly whether CD94 is associated with NKG2A,
proteins were immunoprecipitated with anti-CD94 mAb
from NK-92 cell lysates and analyzed by Western blot with
anti-NKG2A-peptide Ab (Fig. 1) or anti-NKG2 mAb (data
not shown). Under reducing conditions, a 40–45-kD pro-
tein of similar mobility to the protein detected in the
whole cell lysates of NK-92, was detected in anti-CD94
but not control (anti-Ly49) immunoprecipitates (Fig. 1).
Under non-reducing conditions, a 70-kD protein, again of
similar molecular mass to that observed in the NK-92 ly-
sates, was detected by anti-NKG2A-peptide Ab in anti-
CD94 immunoprecipitates. These data indicate that NKG2A
and CD94 form heterodimers.
The 35-kD NKG2A protein was always detected in
whole cell lysates of NKG2A positive cells and is always less
abundant than the 40–45-kD form (Fig. 1, also see Fig. 3).
The fact that anti-peptide-Ab specific for the amino termi-
nus and mAbs-specific for the lectin domains of NKG2A
(data not shown) each react with the 35-kD protein, sug-
gested that it may represent NKG2B. The existence of a
putative NKG2B protein was postulated from the detec-
tion of transcripts (cDNAs) for an alternative splice variant
of NKG2A lacking 54 bases (22). These bases encode 18
amino acids in the stalk or neck region of the protein
which links the lectin domain to the transmembrane region
and contains a potential N-linked glycosylation site. The
absence of this lower molecular mass form in anti-CD94
immunoprecipitates suggests that it lacks the structural re-
quirements for pairing with CD94.
Given that NKG2A forms heterodimers with CD94, we
next determined whether this heterodimer was expressed at
the cell surface and thus was capable of interacting with tar-
get cell ligands. Cell surface proteins from polyclonal NK
cells were labeled with biotin and proteins were immuno-
precipitated with anti-CD94 mAb, anti-NKG2A-peptide
Ab or control Ab. Detection with streptavidin-HRP re-
vealed proteins with a molecular mass of 
 
z
 
40–45 kD and a
group of smaller proteins of molecular mass 25–28 kD in
both the anti-CD94 and anti-NKG2A immunoprecipitates
but not in control immunoprecipitates (Fig. 2). Western
blot analysis of the immunoprecipitated proteins with anti-
NKG2A peptide Ab confirmed the identity of the 40–45-kD
protein as NKG2A (data not shown). The 25–28-kD pro-
teins observed in the anti-CD94 and anti-NKG2A immu-
noprecipitates correspond to the molecular mass of CD94
(14) and, as expected, these proteins did not react with
anti-NKG2A Ab in Western blot analysis (data not shown).
Thus, these data show for the first time that NKG2A is ex-
pressed on the cell surface of polyclonal NK cells and is
complexed to CD94.
Figure 2. NKG2A/CD94 het-
erodimers  are expressed on the
cell surface of polyclonal NK cells.
Cell surface proteins of polyclonal
NK cells were labeled with bi-
otin and immunoprecipitated
with anti-CD94, anti-NKG2A
peptide-specific Ab, anti-Ly49
mAb or, normal rabbit serum
(NRS). Immunoprecipitated pro-
teins were reduced and separated
on SDS-PAGE, transferred to
PVDF, detected with streptavi-
din conjugated-HRP and visual-
ized with enhanced chemilumi-
nescence.
Figure 3. NKG2A fails to mature in the absence of CD94. (A) Whole cell lysates of NK-92 or YT were either digested with Endoglycosidase Hf (1)
or mock digested (2), separated by SDS-PAGE under reducing conditions and analyzed by Western blot with anti-NKG2A peptide-specific Ab. (B)
Anti-CD94, anti-NKG2A or control (anti-Ly49), immunoprecipitates from NK-92 cells were either digested with Endoglycosidase Hf, (1) or mock di-
gested (2), separated by SDS-PAGE under reducing conditions and analyzed by Western blot with anti-NKG2A peptide-specific Ab. (C) NK-92 cell
lysates were exhaustively precleared with control (anti-Ly49), anti-CD94 or anti-NKG2A Ab. The remaining lysates were divided in two and either di-
gested with Endoglycosidase Hf, (1) or mock digested (2), separated by SDS-PAGE under reducing conditions and analyzed by Western blot with anti-
NKG2A peptide Ab. The immunoblots in B and C were overexposed to detect trace amounts of immature CD94-associated NKG2A in B and to em-
phasize that no mature NKG2A could be detected in NK-92 lysates after removal of CD94 associated NKG2A in C. 
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The fact that NKG2A derived from YT migrated as a
monomer under non-reducing conditions (see Fig. 1), in
conjunction with numerous immunoprecipitation experi-
ments which had failed to show cell surface expression of
NKG2A on YT cells (unpublished observations), suggested
that CD94 is required for cell surface expression of NKG2A.
These data also suggest that NKG2A may not fold correctly
in the absence of CD94 and be retained intracellularly. To
analyze the maturation state of NKG2A protein in YT and
NK-92 cells, we made use of the enzyme endoglycosidase
H (Endo H) which cleaves high mannose type polysaccha-
ride side chains that are characteristic of immature glyco-
proteins, but not mature glycoproteins (23). YT and NK-92
cell lysates were either digested with Endo H or mock-
digested and then analyzed by Western blot. This analysis
showed the presence of Endo H–sensitive species of NKG2A
migrating with apparent molecular masses of 
 
z
 
28 kD and
 
z
 
25 kD (after digestion) in the lysates of both NK-92 and
YT (Fig. 3 
 
A
 
). However, mature, Endo H–resistant species
(
 
M
 
r
 
 
 
z
 
43–45 kD) were only observed in NK-92 cells. The
finding that only Endo H–sensitive species of NKG2A
were detected in YT cells indicates that NKG2A does not
transit through the Golgi compartment and suggests that
NKG2A requires the expression of an additional partner,
such as CD94, in order to undergo normal maturation for
cell surface expression.
To show that the maturation of NKG2A is dependent
on the association with CD94, anti-CD94, anti-NKG2A
and control immunoprecipitates from NK-92 cell lysates were
either digested with Endo H or mock-digested and then sub-
jected to Western blot analysis with anti-NKG2A peptide
Ab. As expected, no NKG2A was detected in control anti-
Ly49C immunoprecipitates (Fig. 3 
 
B
 
). The anti-NKG2A
immunoprecipitates contained significant amounts of both
Endo H–sensitive (
 
z
 
28 kD and 
 
z
 
25 kD) and –resistant
species (
 
z
 
43 kD), whereas NKG2A associated with CD94
(anti-CD94 immunoprecipitate) was greatly enriched for ma-
ture, Endo H–resistant NKG2A, such that only trace amounts
of Endo H–sensitive NKG2A were detected (Fig. 3 
 
B
 
).
To confirm these results, NK-92 cell lysates were ex-
haustively precleared with either control (anti-Ly49C),
anti-CD94 or anti-NKG2A peptide Ab. Precleared lysates
were divided in half and digested with Endo H or mock di-
gested and the remaining NKG2A analyzed by immuno-
blot. While both Endo H–resistant and sensitive forms of
NKG2A were observed after preclearing with the control
anti-Ly49C mAb, only Endo H–sensitive forms of NKG2A
were observed after preclearing with anti-CD94 (Fig. 3 
 
C
 
).
As expected, no NKG2A was observed after preclearing
with anti-NKG2A. Collectively, these data show that in
the absence of CD94, NKG2A is retained in the endoplas-
mic reticulum and unlike related proteins such as Ly49 and
NKR-P1 is unable to homodimerize. Furthermore CD94
association is required for maturation and hence cell surface
expression of NKG2A. Transfection studies have shown
cell surface expression of CD94 in the absence of NKG2
proteins (11). It will be interesting to determine whether
CD94 ever exists as a monomer or homodimer on the cell
surface in vivo.
CD94 is expressed on virtually all NK cells, yet the trans-
mission of an inhibitory signal after cross-linking CD94 has
been shown to be restricted to particular NK cell clones
(15–17). Western blot and mRNA analyses of NK cell
clones (unpublished observations) had indicated that the
expression of NKG2A was also restricted to a subset of NK
cells. The cytoplasmic tail of NKG2A has two ITIMs simi-
lar to those found on KIR which can mediate an inhibitory
signal through the association of hematopoietic cell phos-
phatase (24, 25). The presence of such motifs in NKG2A
and the clonal distribution of NKG2A suggested that cross-
linking of the NKG2A/CD94 heterodimer might transduce
the inhibitory signal observed in some NK cell clones (17).
Therefore, we assessed the effects of cross-linking CD94 on
the activation signals delivered through CD16 in redirected
lysis assays using a panel of 11 NK cell clones derived from
two donors, 10 of which expressed NKG2A as detected by
Western blot analyses (data not shown).
Data from three NK cell clones are shown in Fig. 4. Low
levels of lysis of P815 target cells by both the NKG2A pos-
itive clones AR8 and JS22, and the NKG2A negative clone
AR19 were observed in the absence of any mAb (Fig. 4).
As expected, preincubation of P815 cells with anti-CD16
lead to a significant increase in target cell lysis by all clones.
The presence of anti-CD94 had little effect on CD16-
dependent lysis of P815 cells by AR19. However cross-
linking of CD94 on the NKG2A positive clones, AR8 and
JS22, markedly inhibited anti-CD16-mediated lysis of P815
cells to levels comparable with the untreated controls. Our
data suggest that NKG2A expression is required for the
generation of an inhibitory signal after CD94 cross-linking.
However, whether all NK cell clones expressing NKG2A
are inhibited after CD94 cross-linking awaits a more exten-
sive clonal analysis and is the subject of ongoing research.
Figure 4. CD94 cross-linking inhibits CD16-mediated lysis of NKG2A
positive NK cell clones. 51Cr-labeled P815 target cells were either pre-
incubated with anti-CD16 (anti-CD16), or anti-CD16 and anti-CD94
(anti-CD16 1 anti-CD94) or complete medium (untreated) prior to incu-
bation with the NKG2A positive NK cell clones AR8 and JS22 or the
NKG2A negative NK cell clone, AR19 for 4 h. 51Cr released was mea-
sured in a g counter and the percentage of specific lysis calculated. 
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These data do not exclude the possibility that CD94 can
covalently associate with other proteins. In particular, given
the high degree of homology between NKG2A and NKG2C
(22) and the phenotypic differences observed among NK
cell clones after CD94 cross-linking (17), it would seem
likely that CD94 can also associate with NKG2C. NKG2C
has structural features in its transmembrane and cytoplasmic
domains similar to those in the recently described p50 re-
ceptors which activate NK cells upon cross-linking (26,
27). Hence the expression of a putative CD94/NKG2C
heterodimer may be responsible for the signal to engage the
lytic machinery in NK clones which are activated after
CD94 cross-linking.
We have shown that CD94 forms covalent heterodimers
with NKG2A and that association with CD94 is required
for cell surface expression of NKG2A. Furthermore the
generation of an inhibitory signal after cross-linking with
anti-CD94 antibodies correlates with the expression of the
NKG2A protein. Whether the human NKG2A/CD94
protein represents a structurally related, functional counter-
part of the murine Ly49 molecules remains to be deter-
mined.
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Note added in proof:
 
 Since the original submission of this manuscript similar results including a description of
the NKG2A/B-specific mAb 1A12 were reported by Lazetic et al. (Lazetic, S., C. Chang, J.P. Houchins,
L.L. Lanier, and J.H. Phillips. 1996. Human natural killer cell receptors involved in MHC class I recognition
are disulfide-linked heterodimers of CD94 and NKG2 subunits.
 
 J. Immunol
 
. 157:4741–4745).
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